Skip to main content
. 2016 Apr 20;20:511–535. doi: 10.1007/s10157-015-1223-y

Fig. 2.

Fig. 2

Fig. 2

The summary of randomized controlled trials of RAS blockers, antiplatelet agents, and fish oils in adult patients with IgAN